ON Behalf of Niaid-Dcr, Facilitate the Conduct of TWO, Randomized Trials AS Detailed Below in I and II: I. a Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of Covid-19 (2,000 Subjects
Contract Overview
Contract Amount: $89,563,956 ($89.6M)
Contractor: Leidos Biomedical Research Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2020-04-01
End Date: 2028-07-31
Contract Duration: 3,043 days
Daily Burn Rate: $29.4K/day
Official Description: ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS
Place of Performance
Location: Maryland, 21702
State: Maryland Government Spending